NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

OpenAI's Former Chief Scientist Testifies Against CEO Sam Altman

In a California courtroom, Ilya Sutskever, former OpenAI chief scientist, took the stand on Monday, testifying against the company's CEO, Sam Altman. Sutskever revealed that he had spent approximately one year gathering evidence to present to OpenAI's board regarding Altman's "consistent pattern of lying." This testimony comes as part of a legal battle between OpenAI and Elon Musk, a co-founder of the company who left the board in 2018.

Sutskever confirmed that he had prepared a 52-page document detailing Altman's dishonesty at the request of OpenAI's board. He stated that Altman's conduct included "undermining and pitting executives against one another." Sutskever also revealed that he had discussed removing Altman as CEO with then chief technology officer Mira Murati for a long time.

Sutskever's testimony highlights the complexities of OpenAI's leadership and the company's future. His document, which detailed Altman's conduct, was prepared in anticipation of a potential vote to oust Altman as CEO, which ultimately occurred in November 2023. Sutskever played a key role in Altman's firing and subsequent reinstatement, expressing regret over his involvement in the board's actions.

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

YearQuarterly RevenueGrowth Rate
2023$500 million20%
2024$750 million33%
2025$1 billion50%

OpenAI has been raising billions of dollars from investors to build out its computing power ahead of a potential trillion-dollar IPO. Musk, who is seeking $150 billion in damages from OpenAI and its backer Microsoft, has accused the company and Altman of abandoning its nonprofit roots and becoming a for-profit company to enrich themselves.

Sutskever also confirmed that after Altman's brief ouster, the remaining OpenAI board members met with rival Anthropic about a proposal for the Claude chatbot creator to merge with OpenAI and take over its leadership. He stated that he was "not excited" about merging OpenAI with another company. Sutskever's ownership stake in OpenAI was worth approximately $5 billion as of November 2025, and about $7 billion currently.

Closing arguments for the trial will happen on Thursday, U.S. District Judge Yvonne Gonzalez Rogers said. Microsoft CEO Satya Nadella took the stand earlier on Monday, characterizing the tech giant's investment in OpenAI as a "calculated risk," emphasizing that Microsoft considered its early investments to be worthwhile for marketing benefits.

Read also: US-Iran Tensions Spark Uptick in Oil Prices Amid Global Market Decline

Sutskever left OpenAI in 2024 and has since launched an AI startup called Safe Superintelligence. Former and current OpenAI executives, including Greg Brockman, Murati, and Shivon Zilis, have already testified in the trial.

Investor Takeaway

Investors should be cautious of potential leadership changes and their impact on company performance.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.